GC/MS analysis of Tremella fuciformis (White jelly mushrooms) oil

Reginald C. Ohiri

GC/MS analysis of Tremella fuciformis (White jelly mushrooms) oil

2017

Reginald C. Ohiri

The use of mushrooms for the treatment of diseases can be traced to Paleolithic era. One mushroom that has shown potent medicinal properties both by oral consumption and topical application is the Tremella fuciformis. GC/MS analyses of T. fuciformis oil obtained by hydro-distillation showed four predominant compounds. 9,19-Cyclolanost-24-en-3-ol, (3.beta.)- was the most predominant with RT of 20.766 and 24.672 min and a percentage total of 32.681 followed by 7-Isopropenyl-1,4a-dimethyl-4,4a,5 ,6,7,8-hexahydro-3H-naphthalen-2-one with RT of 22.425 min and a percentage total of 21.334, lupeol had RT of 22.825 and 23.230 min and a percentage total of 18.531, while lanosterol had RT of 21.079 and 23.034 min and a percentage total of 17.845. These four compounds represent 90.391% of the total constituent compounds in T. fuciformis oil. The therapeutic properties of two predominant compounds (lanosterol and lupeol) of this mushroom confirm its use for the treatment of both dermatological and ophthalmological related diseases by traditional medical practitioners.

اظهر المزيد [+]